Scientific Advisory Board

Pieter van der Meer, PhD

Dr. Pieter van der Meer is Senior Scientist at Sanquin Blood Supply Foundation in Amsterdam, The Netherlands. His research area includes the conventional blood components, with focus on improvement and extension of red cell and platelet storage. In his position at the Jon J van Rood Center for Clinical Transfusion Research, he performs translational research, trying to establish the relationship between laboratory measures and clinical outcomes of platelet transfusions.

Mike F Murphy, MD

Dr. Mike Murphy is Professor of Blood Transfusion Medicine at the University of Oxford, and a member of the AABB Board of Directors. He was a co-founder of the NHS Blood & Transplant/Medical Research Council Clinical Studies Unit, and the NHS Blood & Transplant Systematic Reviews Initiative for transfusion medicine. He continues to work as a clinical specialist in hematology and transfusion medicine, where his current clinical and laboratory research interests are in the management of hematology patients with severe thrombocytopenia, and the use of new technology for the transfusion process.
For more on Mike Murphy, please click here

Mark D. Scott, PhD

Dr. Mark Scott is a Senior Scientist and Associate Director for Intellectual Property and Business Development at Canadian Blood Services, and Co-founder of Immios Therapeutics. His research efforts are focused on the therapeutic use of ‘immunocamouflaged’ cells/tissues in transfusion and transplantation medicine, prevention of viral invasion and proliferation via broad-spectrum bio-camouflage, and development of novel iron chelators and therapeutic approaches for the amelioration of iron-driven toxicity in sickle cell disease and thalassemia.
For more on Mark Scott, please click here